| PERIOD ENDING | 2-Oct-09 | 3-Jul-09 | 3-Apr-09 | 31-Dec-08 | | Total Revenue | 421,766 | 179,702 | 296,648 | 390,626 | | Cost of Revenue | 227,254 | 104,194 | 159,959 | 216,708 | | | Gross Profit | 194,512 | 75,508 | 136,689 | 173,918 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 136,119 | 111,923 | 117,685 | 151,489 | | Non Recurring | (88) | (17) | 821 | (698) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 58,481 | (36,398) | 18,183 | 23,127 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,732 | 1,965 | (223) | 3,217 | | Earnings Before Interest And Taxes | 61,213 | (34,433) | 17,960 | 26,344 | | Interest Expense | 117 | 117 | 121 | 652 | | Income Before Tax | 61,096 | (34,550) | 17,839 | 25,692 | | Income Tax Expense | 23,339 | (15,306) | 1,962 | 12,554 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 37,757 | (19,244) | 15,877 | 13,138 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,757 | (19,244) | 15,877 | 13,138 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $37,757 | ($19,244) | $15,877 | $13,138 |
|
0.01% Nasdaq 0.00%
Income Statement
